-+ 0.00%
-+ 0.00%
-+ 0.00%

Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket

Benzinga·09/17/2024 09:48:13
Listen to the news

Shares of Intel Corporation (NASDAQ:INTC) rose sharply in today's pre-market trading after the company announced a strategic collaboration with AWS to help advance US-based chip manufacturing.

Intel shares jumped 6.9% to $22.36 in the pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

  • Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) gained 73.1% to $6.70 in pre-market trading after declining around 6% on Monday.
  • Smith Micro Software, Inc. (NASDAQ:SMSI) rose 62.4% to $0.8499 in today's pre-market trading after declining around 9% on Monday.
  • Wheeler Real Estate Investment Trust, Inc. (NASDAQ:WHLR) gained 36.7% to $10.05 in the pre-market trading session after jumping 35% on Monday.
  • Allarity Therapeutics, Inc. (NASDAQ:ALLR) gained 21.3% to $4.10 in pre-market trading.
  • Adagio Medical Holdings, Inc. (NASDAQ:ADGM) rose 16.5% to $4.81 in pre-market trading.
  • Healthy Choice Wellness Corp. (NASDAQ:HCWC) rose 14.5% to $6.00 in pre-market trading after dipping 48% on Monday.
  • Mynaric AG (NASDAQ:MYNA) gained 13.9% to $0.90 in pre-market trading after gaining 13% on Monday.
  • SciSparc Ltd. (NASDAQ:SPRC) shares rose 12% to $0.3490 in pre-market trading. SciSparc-Clearmind Medicine collaboration announced the publication of an international patent application for pioneering ibogaine combination therapy.
  • Avinger, Inc. (NASDAQ:AVGR) gained 10.5% to $1.47 in pre-market trading after the company announced it will be issued the U.S. patent number 12,089,868 for the treatment of occlusive coronary artery disease.

Losers

  • Netcapital Inc. (NASDAQ:NCPL) fell 33% to $1.93 in pre-market trading after reporting first-quarter earnings results.
  • NKGen Biotech, Inc. (NASDAQ:NKGN) shares dipped 19.4% to $0.60 in pre-market trading after declining around 4% on Monday. NKGen Biotech, last week, announced early interim data from the Phase 1 cohort and the dosing of the first Phase 2 patient in the Phase 1/2a clinical trial of troculeucel.
  • Dermata Therapeutics, Inc. (NASDAQ:DRMA) fell 14.2% to $1.99 in pre-market trading after the company announced a $3.5 million private placement priced at-the-market under Nasdaq rules.
  • Golden Heaven Group Holdings Ltd. (NASDAQ:GDHG) shares fell 12.7% to $0.0916 in pre-market trading after gaining 5% on Monday.
  • Bone Biologics Corporation (NASDAQ:BBLG) shares declined 12.7% to $1.65 in pre-market trading after jumping 136% on Monday.
  • CN Energy Group. Inc. (NASDAQ:CNEY) shares fell 11.6% to $0.42 in pre-market trading after gaining around 6% on Monday. CN Energy, last week, announced it received a noncompliance notice from the Nasdaq.
  • Ocean Power Technologies, Inc. (NASDAQ:OPTT) shares declined 9.6% to $0.2259 in pre-market trading following quarterly results.
  • Aptevo Therapeutics Inc. (NASDAQ:APVO) fell 9.1% to $0.30 in today's pre-market trading after announcing a $3.0 million offering priced at-the-market under Nasdaq rules.
  • Tenon Medical, Inc. (NASDAQ:TNON) shares fell 8.7% to $7.04 in pre-market trading.
  • ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA) declined 7.2% to $2.21 in pre-market trading after gaining around 9% on Monday.

Now Read This: